Takip et
Mihaly Koltai
Mihaly Koltai
Imperial College London, Dept Infectious Disease Epi & MRC Centre Global Infectious Disease Analysis
imperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
SignaLink 2–a signaling pathway resource with multi-layered regulatory networks
D Fazekas, M Koltai, D Türei, D Módos, M Pálfy, Z Dúl, L Zsákai, ...
BMC systems biology 7, 1-15, 2013
2312013
Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study
Y Chen, N Li, J Lourenço, L Wang, B Cazelles, L Dong, B Li, Y Liu, M Jit, ...
The Lancet infectious diseases 22 (5), 657-667, 2022
1292022
Secondary bacterial flagellar system improves bacterial spreading by increasing the directional persistence of swimming
S Bubendorfer, M Koltai, F Rossmann, V Sourjik, KM Thormann
Proceedings of the National Academy of Sciences 111 (31), 11485-11490, 2014
752014
The potential for vaccination-induced herd immunity against the SARS-CoV-2 B. 1.1. 7 variant
D Hodgson, S Flasche, M Jit, AJ Kucharski, S Abbott, WJ Edmunds, ...
Eurosurveillance 26 (20), 2100428, 2021
432021
SignaLink3: a multi-layered resource to uncover tissue-specific signaling networks
L Csabai, D Fazekas, T Kadlecsik, M Szalay-Bekő, B Bohár, M Madgwick, ...
Nucleic acids research 50 (D1), D701-D709, 2022
372022
Determinants of RSV epidemiology following suppression through pandemic contact restrictions
M Koltai, F Krauer, D Hodgson, E van Leeuwen, ...
Epidemics 40, 100614, 2022
362022
Sensory input attenuation allows predictive sexual response in yeast
A Banderas, M Koltai, A Anders, V Sourjik
Nature communications 7 (1), 12590, 2016
362016
Optimal respiratory syncytial virus intervention programmes using nirsevimab in England and Wales
D Hodgson, M Koltai, F Krauer, S Flasche, M Jit, KE Atkins
Vaccine 40 (49), 7151-7157, 2022
282022
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa
M Koltai, J Moyes, B Nyawanda, J Nyiro, PK Munywoki, S Tempia, X Li, ...
BMC medicine 21 (1), 120, 2023
222023
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low-and middle-income countries, April 7–8, 2022
MC Fitzpatrick, RS Laufer, R Baral, AJ Driscoll, DR Feikin, JA Fleming, ...
Vaccine 41 (48), 7047-7059, 2023
102023
Exact solving and sensitivity analysis of stochastic continuous time Boolean models
M Koltai, V Noel, A Zinovyev, L Calzone, E Barillot
BMC bioinformatics 21, 1-22, 2020
6*2020
Estimating RSV seasonality from pandemic disruptions: a modelling study
F Krauer, TE Fjelde, M Koltai, D Hodgson, M Treskova-Schwarzbach, ...
medRxiv, 2022.06. 18.22276591, 2022
42022
Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study
F Krauer, F Guenther, M Treskova-Schwarzbach, V Schoenfeld, M Koltai, ...
BMC medicine 22 (1), 478, 2024
22024
The potential global impact and cost-effectiveness of next-generation influenza vaccines: a modelling analysis
L Goodfellow, SR Procter, M Koltai, NR Waterlow, JAN Filipe, CKH Wong, ...
medRxiv, 2024.09. 19.24313950, 2024
12024
The benefits and risks of maternal RSV vaccination on mortality in South Africa: a modelling study
A Monoi, A Endo, SR Procter, SI Leuba, S Flasche, P Beutels, C Cohen, ...
medRxiv, 2025.02. 14.25321914, 2025
2025
Date of introduction and epidemiologic patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Mogadishu, Somalia: estimates from transmission modelling of …
M Koltai, A Warsame, F Bashiir, T Freemantle, C Reeve, C Williams, M Jit, ...
Wellcome Open Research 6, 255, 2022
2022
Quantitative analysis of microbial sensing and motility
M Koltai
2016
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–17